title: Relation between circulating soluble Fas ligand and subsequent ventricular remodelling following myocardial infarction.
authors.forename: T
authors.initials: T
authors.lastname: Soeki
authors.forename: Y
authors.initials: Y
authors.lastname: Tamura
authors.forename: H
authors.initials: H
authors.lastname: Shinohara
authors.forename: K
authors.initials: K
authors.lastname: Sakabe
authors.forename: Y
authors.initials: Y
authors.lastname: Onose
authors.forename: N
authors.initials: N
authors.lastname: Fukuda
mesh_terms: D053222:Fas Ligand Protein; D005260:Female; D006801:Humans; D008297:Male; D008562:Membrane Glycoproteins / Q000097:blood*; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood* / Q000503:physiopathology; D020257:Ventricular Remodeling / Q000502:physiology*
chemical_list: C505661:FASLG protein, human; D053222:Fas Ligand Protein; D008562:Membrane Glycoproteins